A word of caution: reopening chronic coronary occlusions.
Reopening of chronically occluded coronary arteries by angioplasty, initially considered a low risk procedure, may carry similar risks at PTCA of coronary stenoses. We report 3 cases with ventricular fibrillation or sudden death 2-4 days after reopening of 1- to 5-month-old coronary occlusions.
Burger
W
W
Department of Cardiology, University Hospital Frankfurt, Germany.
Kadel
C
C
Keul
H G
HG
Vallbracht
C
C
Kaltenbach
M
M
D000368:Aged; D000784:Aortic Dissection / Q000000981:diagnostic imaging / Q000473:pathology / Q000503:physiopathology; D015906:Angioplasty, Balloon, Coronary / Q000295:instrumentation*; D003131:Combined Modality Therapy; D003323:Coronary Aneurysm / Q000000981:diagnostic imaging / Q000473:pathology / Q000503:physiopathology; D017023:Coronary Angiography; D003328:Coronary Thrombosis / Q000000981:diagnostic imaging / Q000473:pathology / Q000503:physiopathology / Q000628:therapy*; D003331:Coronary Vessels / Q000473:pathology; D005080:Exercise Test; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000000981:diagnostic imaging / Q000473:pathology / Q000503:physiopathology / Q000628:therapy*; D012008:Recurrence; D012770:Shock, Cardiogenic / Q000000981:diagnostic imaging / Q000473:pathology / Q000503:physiopathology / Q000628:therapy*; D015912:Thrombolytic Therapy; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage*
D014568:Urokinase-Type Plasminogen Activator